BRPI0407430A - Sal do ácido benzenossulfÈnico com clopidogrel, processos para preparação do mesmo, e para purificação de clopidogrel, uso de um sal, formulação farmacêutica, partìculas de substância ativa, uso de partìculas de substância ativa, e, processo para preparação de partìculas de substância ativa - Google Patents

Sal do ácido benzenossulfÈnico com clopidogrel, processos para preparação do mesmo, e para purificação de clopidogrel, uso de um sal, formulação farmacêutica, partìculas de substância ativa, uso de partìculas de substância ativa, e, processo para preparação de partìculas de substância ativa

Info

Publication number: BRPI0407430A
Authority: BR; Brazil
Prior art keywords: active substance; substance particles; clopidogrel; preparation; salt
Prior art date: 2003-02-13

Application number

BR0407430-0A

Other languages

English (en)

Portuguese (pt)

Inventor

Karlheinz Doser

Klaus Glonzer

Original Assignee

Helm Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-13

Filing date

2004-02-13

Publication date

2006-01-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32797377&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0407430(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-02-13 Application filed by Helm Ag filed Critical Helm Ag

2006-01-24 Publication of BRPI0407430A publication Critical patent/BRPI0407430A/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4743—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Steroid Compounds (AREA)

BR0407430-0A 2003-02-13 2004-02-13 Sal do ácido benzenossulfÈnico com clopidogrel, processos para preparação do mesmo, e para purificação de clopidogrel, uso de um sal, formulação farmacêutica, partìculas de substância ativa, uso de partìculas de substância ativa, e, processo para preparação de partìculas de substância ativa BRPI0407430A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10305984A DE10305984A1 (de)	2003-02-13	2003-02-13	Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
PCT/EP2004/001369 WO2004072084A1 (de)	2003-02-13	2004-02-13	Salz der benzolsulfonsäure mit clopidogrel und dessen verwendung zur herstellung pharmazeutischer formulierungen

Publications (1)

Publication Number	Publication Date
BRPI0407430A true BRPI0407430A (pt)	2006-01-24

Family

ID=32797377

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR0407430-0A BRPI0407430A (pt)	2003-02-13	2004-02-13	Sal do ácido benzenossulfÈnico com clopidogrel, processos para preparação do mesmo, e para purificação de clopidogrel, uso de um sal, formulação farmacêutica, partìculas de substância ativa, uso de partìculas de substância ativa, e, processo para preparação de partìculas de substância ativa

Country Status (15)

Country	Link
US (2)	US20050256152A1 (de)
EP (4)	EP1592694B1 (de)
JP (1)	JP2006515338A (de)
KR (3)	KR100805176B1 (de)
AT (3)	ATE290535T1 (de)
BR (1)	BRPI0407430A (de)
CA (2)	CA2468089A1 (de)
DE (5)	DE10305984A1 (de)
DK (2)	DK1480985T3 (de)
ES (2)	ES2236679T3 (de)
MX (1)	MXPA05007557A (de)
PL (2)	PL378572A1 (de)
PT (2)	PT1592694E (de)
SI (2)	SI1592694T1 (de)
WO (2)	WO2004072084A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002217464B2 (en) *	2000-12-25	2004-12-16	Daiichi Sankyo Company, Limited	Medicinal compositions containing aspirin
DE10305984A1 (de)	2003-02-13	2004-09-02	Helm Ag	Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
DK1618111T3 (en) *	2003-04-25	2015-02-16	Cadila Healthcare Ltd	Salts of clopidogrel and the process for preparing
DK1680430T3 (da) *	2003-11-03	2010-05-25	Cadila Healthcare Ltd	Fremgangsmåder til fremstilling af form I af (S)-(+)-Clopidogrel-bisulfat
RU2006133842A (ru) *	2004-02-24	2008-03-27	Зигфрид Дженерикс Интерэшнл Аг (Ch)	Фармакологически приемлемые соли клопидогрела
EP2386560A1 (de) *	2004-04-09	2011-11-16	Hanmi Holdings Co., Ltd.	Kristallines Clopidogrelnaphthalinsulfonat-Hydrat, Verfahren zu dessen Herstellung und pharmazeutische Zusammensetzung, die dieses enthält
KR100563455B1 (ko) *	2004-04-09	2006-03-23	한미약품 주식회사	결정성 클로피도그렐 나프탈렌술폰산염 또는 이의 수화물,이의 제조방법 및 이를 함유하는 약학적 조성물
ZA200608569B (en) *	2004-04-20	2007-12-27	Sanofi Aventis	Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide
KR20070012676A (ko) *	2004-04-20	2007-01-26	사노피-아벤티스	클로피도그렐 염 및 그의 다형성 형태
EP1802280A4 (de) *	2004-10-14	2008-02-20	Reddys Lab Ltd Dr	Clopidogrel-zusammensetzungen
TWI347942B (en) *	2005-06-22	2011-09-01	Lundbeck & Co As H	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP1934229B1 (de)	2005-09-05	2012-09-26	Cadila Healthcare Limited	Verfahren zur herstellung verschiedener formen von (s)-(+)-clopidogrel-besylat
WO2007054968A2 (en) *	2005-09-20	2007-05-18	Torrent Pahrmaceuticals Limited	Novel pharmaceutical compositions of clopidogrel mesylate
US20080226579A1 (en) *	2005-09-21	2008-09-18	Chong Kun Dang Pharmaceutical Corp.	Novel Resinate Complex of S-Clopidogrel and Production Method Thereof
KR100791687B1 (ko) *	2006-02-27	2008-01-03	채종근	결정성 클로피도그렐 설포살리실산 염을 포함하는 제제
KR100945062B1 (ko) *	2006-03-22	2010-03-05	한미약품 주식회사	클로피도그렐 1,5-나프탈렌디술폰산염 및 이의 수화물의제조방법
KR100834967B1 (ko) *	2006-08-11	2008-06-03	에스케이케미칼주식회사	여액의 라세미화 반응에 의한 ｓ-(＋)-클로피도그렐의고수율 제조방법
EP1900358A1 (de) *	2006-09-16	2008-03-19	Cimex Pharma AG	Clopidogrel enthaltende Arzneiformulierungen
DE602007012497D1 (de) *	2006-09-25	2011-03-31	Adamed Sp Zoo	Neues Clopidogrel-Salz und seine kristallinen Formen
CN100400035C (zh) *	2006-10-18	2008-07-09	深圳信立泰药业股份有限公司	氯吡格雷硫酸盐的固体制剂及其制备方法
US20100062066A1 (en) *	2006-11-14	2010-03-11	Acusphere, Inc	Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
US7960550B2 (en)	2006-11-24	2011-06-14	Cadila Healthcare Limited	Process for preparing (S)-(+)-clopidogrel base and its salts
WO2008081473A2 (en) *	2006-12-29	2008-07-10	Cadila Healthcare Limited	Process for preparing clopidogrel
WO2008134600A1 (en)	2007-04-27	2008-11-06	Cydex Pharmaceuticals, Inc.	Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
KR20090022616A (ko) *	2007-08-31	2009-03-04	한올제약주식회사	베실산클로피도그렐 함유 경구투여용 약제
KR100920932B1 (ko) *	2007-12-05	2009-10-20	한림제약(주)	결정형의 클로피도그렐 벤젠술폰산염의 제조방법
EP2107061A1 (de)	2008-04-02	2009-10-07	Krka Tovarna Zdravil, D.D., Novo Mesto	Herstellungsverfahren für optisch angereichertes Clopidogrel
CA2761455C (en)	2009-05-13	2018-06-12	Cydex Pharmaceuticals, Inc.	Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
WO2012123958A1 (en)	2011-02-14	2012-09-20	Cadila Healthcare Limited	Highly pure salts of clopidogrel free of genotoxic impurities
CN102199161B (zh) *	2011-03-30	2013-07-03	天津红日药业股份有限公司	一种苯磺酸氯吡格雷晶型ⅰ及其制备方法和用途
CN102285996A (zh) *	2011-03-30	2011-12-21	天津红日药业股份有限公司	一种苯磺酸氯吡格雷晶型ⅱ及其制备方法和用途
HUP1400294A2 (hu)	2014-06-13	2015-12-28	Skillpharm Kft	Clopidogrel új alkalmazása
CN104193762B (zh) *	2014-08-04	2017-02-15	浙江车头制药股份有限公司	一种制备苯磺酸氯吡格雷晶型ⅲ的方法
CN115327005B (zh) *	2022-08-12	2024-01-26	成都施贝康生物医药科技有限公司	一种氧化氯吡格雷有关物质的检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2530247B1 (fr) *	1982-07-13	1986-05-16	Sanofi Sa	Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) *	1987-02-17	1992-01-24	Sanofi Sa	Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2740686B1 (fr) *	1995-11-03	1998-01-16	Sanofi Sa	Formulation pharmaceutique lyophilisee stable
US6509348B1 (en) *	1998-11-03	2003-01-21	Bristol-Myers Squibb Company	Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
KR100768034B1 (ko) *	1999-03-17	2007-10-17	다이이찌 세이야꾸 가부시기가이샤	의약 조성물
DE10109763A1 (de) *	2001-02-28	2002-09-05	Gruenenthal Gmbh	Pharmazeutische Salze
DE10153078A1 (de) *	2001-10-30	2003-05-22	Degussa	Verwendung von Granulaten auf Basis von pyrogen hergestelltem Siliciumdioxid in pharmazeutischen Zusammensetzungen
IL166593A0 (en) *	2002-08-02	2006-01-15		Racemization and enantiomer separation of clopidogrel
DE10305984A1 (de)	2003-02-13	2004-09-02	Helm Ag	Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
DK1618111T3 (en) *	2003-04-25	2015-02-16	Cadila Healthcare Ltd	Salts of clopidogrel and the process for preparing

2003
- 2003-02-13 DE DE10305984A patent/DE10305984A1/de not_active Withdrawn
2004
- 2004-02-13 WO PCT/EP2004/001369 patent/WO2004072084A1/de active Application Filing
- 2004-02-13 DK DK04700011T patent/DK1480985T3/da active
- 2004-02-13 EP EP04710847A patent/EP1592694B1/de not_active Revoked
- 2004-02-13 KR KR1020047016562A patent/KR100805176B1/ko not_active Expired - Lifetime
- 2004-02-13 ES ES04700011T patent/ES2236679T3/es not_active Expired - Lifetime
- 2004-02-13 EP EP04700011A patent/EP1480985B1/de not_active Revoked
- 2004-02-13 MX MXPA05007557A patent/MXPA05007557A/es active IP Right Grant
- 2004-02-13 AT AT04700011T patent/ATE290535T1/de not_active IP Right Cessation
- 2004-02-13 JP JP2006500030A patent/JP2006515338A/ja active Pending
- 2004-02-13 DE DE202004021399U patent/DE202004021399U1/de not_active Expired - Lifetime
- 2004-02-13 EP EP05009790A patent/EP1595884B1/de not_active Expired - Lifetime
- 2004-02-13 AT AT05009790T patent/ATE512153T1/de active
- 2004-02-13 SI SI200430313T patent/SI1592694T1/sl unknown
- 2004-02-13 ES ES04710847T patent/ES2282848T3/es not_active Expired - Lifetime
- 2004-02-13 DK DK04710847T patent/DK1592694T3/da active
- 2004-02-13 DE DE502004000002T patent/DE502004000002D1/de not_active Revoked
- 2004-02-13 BR BR0407430-0A patent/BRPI0407430A/pt not_active IP Right Cessation
- 2004-02-13 WO PCT/EP2004/001370 patent/WO2004072085A2/de active IP Right Grant
- 2004-02-13 SI SI200430001T patent/SI1480985T1/xx unknown
- 2004-02-13 CA CA002468089A patent/CA2468089A1/en not_active Abandoned
- 2004-02-13 DE DE202004021381U patent/DE202004021381U1/de not_active Ceased
- 2004-02-13 DE DE502004003680T patent/DE502004003680D1/de not_active Expired - Lifetime
- 2004-02-13 PT PT04710847T patent/PT1592694E/pt unknown
- 2004-02-13 KR KR10-2004-7016868A patent/KR20050008692A/ko not_active Ceased
- 2004-02-13 PL PL378572A patent/PL378572A1/pl not_active Application Discontinuation
- 2004-02-13 PT PT04700011T patent/PT1480985E/pt unknown
- 2004-02-13 AT AT04710847T patent/ATE361305T1/de active
- 2004-02-13 CA CA002481848A patent/CA2481848C/en not_active Expired - Fee Related
- 2004-02-13 KR KR1020067018596A patent/KR20060103472A/ko not_active Ceased
- 2004-02-13 EP EP05009789A patent/EP1586575A3/de not_active Withdrawn
- 2004-02-13 PL PL04373512A patent/PL373512A1/xx not_active Application Discontinuation
- 2004-02-13 US US10/510,578 patent/US20050256152A1/en not_active Abandoned
2005
- 2005-04-25 US US11/113,467 patent/US20050203122A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004072085A2 (de)	2004-08-26
DE502004003680D1 (de)	2007-06-14
EP1586575A2 (de)	2005-10-19
WO2004072084A1 (de)	2004-08-26
EP1480985A1 (de)	2004-12-01
MXPA05007557A (es)	2005-11-17
CA2468089A1 (en)	2004-08-13
EP1480985B1 (de)	2005-03-09
EP1595884A3 (de)	2006-09-06
EP1595884B1 (de)	2011-06-08
DK1480985T3 (da)	2005-06-06
DE202004021381U1 (de)	2007-11-15
KR20060103472A (ko)	2006-09-29
KR100805176B1 (ko)	2008-02-21
US20050203122A1 (en)	2005-09-15
ES2282848T3 (es)	2007-10-16
SI1592694T1 (sl)	2007-08-31
US20050256152A1 (en)	2005-11-17
PL373512A1 (en)	2005-09-05
EP1592694B1 (de)	2007-05-02
ES2236679T3 (es)	2005-07-16
PT1480985E (pt)	2005-05-31
WO2004072085A3 (de)	2004-10-28
JP2006515338A (ja)	2006-05-25
ATE512153T1 (de)	2011-06-15
KR20040101503A (ko)	2004-12-02
DE10305984A1 (de)	2004-09-02
CA2481848A1 (en)	2004-08-26
KR20050008692A (ko)	2005-01-21
ATE361305T1 (de)	2007-05-15
DE202004021399U1 (de)	2007-11-22
EP1586575A3 (de)	2006-09-06
EP1592694A2 (de)	2005-11-09
EP1595884A2 (de)	2005-11-16
ATE290535T1 (de)	2005-03-15
DK1592694T3 (da)	2007-08-13
SI1480985T1 (en)	2005-06-30
PT1592694E (pt)	2007-06-14
PL378572A1 (pl)	2006-05-02
CA2481848C (en)	2006-10-10
DE502004000002D1 (de)	2005-04-14

Publication	Publication Date	Title
BRPI0407430A (pt)	2006-01-24	Sal do ácido benzenossulfÈnico com clopidogrel, processos para preparação do mesmo, e para purificação de clopidogrel, uso de um sal, formulação farmacêutica, partìculas de substância ativa, uso de partìculas de substância ativa, e, processo para preparação de partìculas de substância ativa
BRPI0307117B8 (pt)	2021-05-25	amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos
BRPI0410029B8 (pt)	2021-06-15	composto dihidroquinazolina substituído, processo para sua preparação, medicamento compreendendo o referido composto e uso do referido composto
CL2003002683A1 (es)	2005-04-08	Enantiomeros s de compuestos derivados del acido (2s)-3-4(-{2-amino-2-oxoetoxi}fenil)-2-etoxipropanoico; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento o prevencion de trastornos de lipidos,
BRPI0514691A (pt)	2008-06-17	composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
BR0112693B1 (pt)	2013-02-05	(derivados) de Ácido sulfonilaminometilbenzàico substituÍdos, bem como processo para preparaÇço e uso dos mesmos.
BR112013029862A2 (pt)	2016-12-20	derivados de piridin-2 (1h)-ona úteis como medicamentos para o tratamento de distúrbios mieloproliferativos, rejeição a transplante, doenças imunomediadas e inflamatórias
ECSP034437A (es)	2003-03-31	Sales estables de acido o-acetilsalicilico con aminoacidos basicos
ECSP003589A (es)	2002-02-25	Compuestos organicos
CL2007002099A1 (es)	2008-02-22	Compuestos derivados de 3h-espiro(1-benzofuran-2,4'-piperidina); proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso para el tratamiento de enfermedades respiratorias, tales como epoc y asma.
WO2004055006A8 (en)	2005-06-30	Novel compounds having selective inhibiting effect at gsk3
SE0200979D0 (sv)	2002-03-28	New compounds
BR0317358A (pt)	2005-12-13	Composto de pirrolopiridazina, processo para sua preparação, composição farmacêutica contendo o mesmo, método de prevenção ou tratamento de doenças contendo o mesmo e seu uso
BR0206935A (pt)	2004-06-29	Composto, formulação farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de condições associadas com a inibição da glicogênio sintase quinase-3, e, processo para a preparação de um composto
WO2009098715A3 (en)	2009-10-15	Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
PA8622401A1 (es)	2005-08-10	Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico,procesos para su preparacion y su uso como medicamentos
BR0208887A (pt)	2004-06-29	Derivados de dihidro-benzo[b][1,4]diazepin-2-ona como antagonistas i de mglur2
UA104988C2 (uk)	2014-04-10	Похідні піроніндолу та спосіб їх отримання
UY28702A1 (es)	2005-07-29	Derivados de quinazolina
BRPI0414948A (pt)	2006-11-07	derivados de pirazolo-e-imidazo pirimidina
SV2004001555A (es)	2004-03-19	Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos
BRPI0411503A (pt)	2006-07-25	composto, composição farmacêutica, uso de um composto, método de tratar um ser humano que sofre de uma doença hiperproliferativa tal como cáncer, e, processo para a preparação de um composto
NO20042158L (no)	2004-08-27	Substituert 4-fenyl-tetrahydroisokinoliner, fremgangsmate for fremstilling derav, anvendelse derav som medikamenter, i tillegg til medikamenter inneholdende samme
EA200601846A1 (ru)	2007-04-27	Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
EP1602362A4 (de)	2008-11-05	Arzneimittelzusammensetzung mit wirkstoff, der in hoher konzentration an einen kugelförmigen kern anhaftet

Legal Events

Date	Code	Title	Description
2012-05-22	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 7A E 8A ANUIDADES.
2012-10-16	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.